Key result
Visceral abdominal fat and hepatic fat fraction were independently associated with increasing left-ventricular remodeling index (β=0.11 and 0.06, respectively) regardless of hyperglycemic state.
Observational (n=374)
Visceral abdominal fat and hepatic fat fraction are associated with subclinical left-ventricular remodeling in a healthy population, independent of glycemic status.
Answers are grounded in this paper and cite their sources.
Should not yet change practice; hypothesis-generating for visceral/hepatic fat in LV remodeling research.
Local, abdominal fat depots may be related to alterations in cardiac function and morphology due to a metabolic linkage. Thus, we aimed to determine their association with subtle cardiac changes and the potential interaction with hyperglycemic metabolic states. Subjects from the general population and without history of cardiovascular disease were drawn from the Cooperative Health Research in the Region of Augsburg FF4 cohort and underwent 3 T cardiac and body MRI. Measures of abdominal adiposity such as hepatic proton-density fat fraction [PDFFhepatic], subcutaneous (SAT) and visceral abdominal fat (VAT) as well as established cardiac left-ventricular (LV) measures including LV remodeling index (LVCI) were derived. Associations were determined using linear regression analysis based on standard deviation normalized predictors. Among a total of 374 subjects (56.2 ± 9.1 years, 58% males), 49 subjects had diabetes, 99 subjects had prediabetes and 226 represented normal controls. Only subtle cardiac alterations were observed (e.g. LVCI: 1.13 ± 0.30). While SAT was not associated, increasing VAT and increasing PDFFhepatic were independently associated with increasing LVCI (β = 0.11 and 0.06, respectively), decreasing LV end-diastolic volume (β = − 6.70 and 3.23, respectively), and decreasing LV stroke volume (β = − 3.91 and − 2.20, respectively). Hyperglycemic state did not modify the associations between VAT or PDFF and LV measures (interaction term: all p ≥ 0.29). In a healthy population, VAT but also PDFFhepatic were associated with subclinical measures of LV remodeling without evidence for a modifying effect of hyperglycemic state.
No takes yet. Share an insight, caveat, or question.
Schlett et al. (2018) conducted an observational in Diabetics, prediabetics and normal controls without history of cardiovascular disease (n=374). Abdominal adiposity (visceral abdominal fat and hepatic proton-density fat fraction) was evaluated on Left-ventricular remodeling index (LVCI) (β = 0.11 for VAT, β = 0.06 for PDFFhepatic). Visceral abdominal fat and hepatic fat fraction were independently associated with increasing left-ventricular remodeling index (β=0.11 and 0.06, respectively) regardless of hyperglycemic state.
Synapse has enriched 10 related papers. Consider them for comparative context: